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Rabbit platelets  in plasma exposed to bacterial endotoxin undergo aggrega- 
tion, fusion, and release of several biologically active platelet factors (1). Since 
a  superficially  similar  type  of platelet  injury  can be  produced  by thrombin, 
some  investigators  have  proposed  that  platelet  injury  in  in  vitro  systems  is 
produced  by elaboration  of small  quantities  of  thrombin  which  cause  poly- 
merization  of fibrinogen  adherent  to  platelet  surfaces  but  are  insufficient  to 
produce gross clotting (2). Application of this formulation to the platelet injury 
induced  by endotoxin requires  the  assumption  that  endotoxin  interacts  with 
components  of plasma  to  produce  thrombin  mad  that  the  observed  platelet 
changes are secondary. 
Previously this laboratory has reported studies suggesting that the coagula- 
tion acceleration observed when endotoxin is added to blood in vitro is a  result 
of platelet  injury rather  than  its  cause  (3).  The present  studies  were under- 
taken  to  further  define  and  compare  the  nature  of  endotoxin-induced  and 
thrombin-induced platelet damage. 
Materials and Methods 
A lipopolysaccharide endotoxin of the bovine type prepared from Escherickia coli 0127  :B8 
(Difco Laboratories Inc., Detroit)  was used in a final concentration  of 2 mg per ml in normal 
saline. Varying lots of this material were found to differ in their platelet-injuring  effects and 
accordingly only active lots were used. Bovine topical thrombin (Parke, Davis & Co., Detroit) 
was freshly mixed with the provided  diluent  and further diluted with normal saline to the 
desired NIH unit strength.  One NIH unit is defined as that amount of thrombin which, when 
mixed in 0.1 ml volume with 0.1 ml of bovine fibrinogen solution in a concentration  of 3 mg 
per ml (Warner-Lambert-Chilcott,  Morris Plains, New Jersey) will cause clot formation in 15 
seconds. 3.8 per cent sodium citrate was employed in a final concentration of one part to nine 
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parts  blood,  and  fresh  solutions of heparin  without preservative (Connought Laboratories, 
Toronto, Canada)  were employed in some experiments in the concentrations indicated. 
The methods of preparation of platelet-rich plasma and platelet-poor plasma by differential 
centrifugation, platelet enumeration, and 5-hydroxytryptamine (5 HT) assay and preparation 
of siliconized pyrogen-free glassware have been previously described (1). 
EXPERIMENTAL 
Stability of 5 HT in  Various Solutions.--These experiments have utilized 
release of platelet 5 HT into plasma  in vitro as an index  of platelet damage. In 
the course of the experiments it became apparent that changes in the distribu- 
tion of 5 HT between  platelets and plasma are influenced  not only  by platelet 
injury but also by deterioration  of 5 HT in plasma, absorption  of plasma  5 HT 
onto normal platelets, and slow spontaneous release of 5 HT from platelets. 
These three processes are demonstrated  in the experiments illustrated  in Figs. 
I and 2. 
5 HT in a final concentration of 5 #g per ml was added to platelet-poor plasma and to saline. 
These materials were incubated at 37°C,  aliquots were removed at intervals, and the concen- 
tration of 5 HT determined (Fig. 1). 
In the experiment illustrated in Fig. 2, 5 HT in a concentration of 5 ~g per ml was added 
to platelet-rich plasma already containing endogenous 5 HT in a concentration of 9 ~g per 
ml. This material was similarly rotated and incubated,  aliquots were removed at intervals, 
and centrifuged at high speeds in the cold to separate platelets and plasma. 5 HT concentra- 
tion was assayed  directly in the plasma.  Platelets were resuspended  in a  volume of saline 
equal to the plasma from which they had been separated, lysed by three cycles of freezing 
and thawing, and the 5 HT concentration of the platelet lysate determined. 
Less than one-half of the initially added 5 HT was recovered after 120 min- 
utes' incubation, indicating that deterioration in plasma at 37°C is fairly rapid 
(Fig. 1). Paired aliquots of the plasma carried through three cycles of freezing 
and thawing did not demonstrate any increase in 5 HT content. This indicated 
that virtually no platelets remained after high speed centrifugation and elimi- 
nated the possibility  that disappearance  of plasma 5  HT might be  due  to 
absorption onto small numbers of unsedimented platelets (vide infra).  5 HT 
in buffered saline at 37°C was considerably more stabile, over 75 per cent being 
recovered  after 2 hours' incubation. Other experiments  not documented here 
indicate that 5 HT is quite stabile for periods up to 8 hours in plasma kept at 
4°C. Fig. 2 illustrates that 5 HT added to platelet-rich plasma becomes com- 
pletely bound to platelets during incubation for 1 hour. The subsequent decrease 
in platelet 5 HT concentration is presumably due to slow spontaneous  release 
of 5 HT from platelets and its subsequent destruction in plasma.  All these 
processes influence the results of the experiments to be described. 
Comparison of the Ejects of Endotoxin and Thrombin on Citrated Platelet-Rich 
Plasma.--The patterns of platelet injury induced by endotoxin and by thrombin 
differ in several important respects. ROGER  M.  DES  PREZ  307 
Fig. 3  illustrates the results of an experiment in which platelet-rich plasma was mixed 
with endotoxin (100/~g per ml) in a siliconizcd flask and incubated at 37°C while undergoing 
standardized  agitation. Aliquots were removed at intervals, platelets and plasma separated 
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FIo.  1.  Changes in 5 HT concentration in platelet-poor plasma  (dark bar)  and buffered 
saline (stippled bar) to which 5 HT had been added in a concentration of 5/~g per ml. Mate- 
rials were incubated at 37°C and agitated during the course of the experiment. 
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FzG. 2.  Changes in 5 HT concentration in platelet-rich plasma (iultial 5 HT concentration 
9/~g per ml) to which exogenous 5 HT (5/~g per ml) was added.  Plasma was incubated at 
37°C, agitated, aliquots removed, centrifuged, and assayed for plasma and platelet 5 HT con- 
centration. 
by centrifugation in the cold, and the plasma and platelet S HT concentrations determined 
as previously described. 
In a parallel experiment (Fig. 4) platelet-rich plasma was divided among 5 siliconized cen- 
trifuge tubes,  thrombin was added in a concentration of 5 NIH units per ml of plasma, and all 308  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  III 
tubes were sealed with parafilm and incubated while undergoing agitation. At the indicated 
intervals single tubes were  removed, plasma was separated from the gel clot by expression 
with applicator sticks and subsequent centrifugation, and the 5 HT content of plasma and the 
platelet-fibrin residues was determined. 
Control aliquots of platelet-rich plasma incubated with saline demonstrated no transfer of 
5 HT from platelets to plasma over the period of the experiment. 
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tions over the course of incubation of rabbit platelet-rich plasma with endotoxin (100 ~g per ROGER  ~.  DES  m~,~z  309 
In interaction of platelets and endotoxin (Fig.  3), an appreciable lag period 
occurs before release of 5 HT is observed. This then progresses  until virtually 
all of the 5 HT has been released from platelets. The concentration of 5 HT 
in plasma in the experiment illustrated was greatest at 60 minutes' incubation 
and subsequently declined  somewhat due to deterioration of 5 HT in plasma 
even though release of platelet 5 HT continued. No clot formation was observed 
under these conditions.  In contrast (Fig. 4) when thrombin and platelets inter- 
acted, the greatest plasma 5 HT concentration appeared immediately and the 
reaction  was not progressive.  The  decrease in  plasma  5  HT concentrations 
observed in the later specimens  appeared to be due in part to deterioration of 
5 HT in plasma and in part re.absorption of 5 HT onto the platelet-fibrin mesh. 
In all instances, a gross fibrin clot appeared immediately. 
TABLE I 
Effect of Graded Concentrations of Thrombin on Clot Formation and Release of Platdet 5 HT 
in Citrated Platelet-Rick Plasma 
1 rain. after thrombln  60 mln. after thrombin 
Thrombin added  5 HT recovered  5 HT recovered 
NIH u./rnl 
0.5 
1 
2 
3 
4 
5 
Clot formation 
0 
+ 
+ 
+ 
+ 
+ 
Pl~ma  Pl~e~ 
!  I00 
2  87 
2 
13  61 
55  50 
6O  35 
Clot formation 
0 
+ 
+ 
+ 
+ 
+ 
Plasma  Platele~ 
per ce~t  per cen~ 
1  97 
1  71 
1  75 
2  60 
15  50 
28  35 
Determination  of  the  Minimum  Thrombin  Concentrations  Required for  Clot 
Formation  and  for  Platelet  Damage  in  Citrated  Platdet-Rich  Plasma.--The 
observed lag period in the endotoxin-platelet interaction might represent time 
required for the elaboration of thrombin in concentrations insufficient  to cause 
gross clot but adequate to polymerize platelet fibrinogen  and thereby damage 
platelets. However, experiments to test this point (Table I) indicated that the 
concentration of thrombin adequate to coagulate citrated platelet-rich plasma 
was appreciably less than that required to produce release  of platelet 5 I-IT. 
Plasma 5 HT concentrations are greater in the 1 minute specimens than in the 
1 hour specimens,  for reasons indicated above. 
Effects of Heparin  on the  Thrombin-Platelet  Reactions  as Compared with the 
Endotoxin-Platdet  Reaction.--The  action  of  thrombin  on  fibrinogen  and  on 
platelets is relatively insensitive to inhibition by sodium citrate, but is quite 
sensitive to inhibition by heparin. As illustrated in Table II, a thrombin con- 310  BACTERIAL ENDOTOXlN  AND  RABBIT  PLATELETS.  I~ 
centration  of 5  NIH  units  per  ml  was  without  effect  either  on  platelets or 
fibrinogen in platelet-rich plasma containing heparin 100/~g per ml, and when 
TABLE II 
Effect of Heparin on Release of Platdet 5 HT by Thrombin  and by Endotoxin 
Heparin 
pg/r~ 
0 
100 
100 
100 
100 
1000 
1000 
1000 
1000 
Additives (O.lml per mlplasnm)  5 HT recovered in plasma 
Time incubated 
Thrombin  Endotoxin 
NIH u./ml  I.~glml 
5 
100 
5  100 
5 
100 
25  100 
25 
Saline 
m/ 
0.2 
0.2 
0.1 
0.2 
0.3 
0.2 
0.1 
0.2 
0.3 
1 miB.  90 mln. 
per c~'~l  per cen~ 
60  22 
1  50 
1  53 
1  i 
1  1 
1  46 
1  31 
1  2 
1  1 
TABLE III 
Effect of Graded Concentrations  of Heparin on Release of Platdet 5 HT by Endotoxin 
Hepsrln 
pg/~ 
100 
100 
5OO 
1000 
25OO 
5000 
Additive* 
Saline 
Endotoxin* 
¢¢ 
~c 
Time after addition of endotoxin 
I 
1 rain.  1  90 rain. 
5 HT recovered 
Platelets  Plasma  Platelets  Plasma 
per ient  I 
1 
1 
1 
1 
p#r cent 
100 
100 
100 
100 
100 
100 
per cenl 
1 
60 
38 
34 
12 
1 
#er cent 
100 
26 
38 
40 
60 
100 
* 100 #g per ml platelet-rich plasma. 
the concentration of heparin was  increased to  1 mg per ml, a  thrombin  con- 
centration  of  25  NIH  units  was  insufficient  to  produce  platelet damage.  In 
contrast  (Table III), platelet damage  by endotoxin is  seen  at both  of these 
concentrations of heparin, and it is necessary to increase the concentration of 
heparin to 5 mg per ml of platelet-rich plasma to completely inhibit this prop- 
erty of endotoxin. Roo~a  ~r.  D~S  ~'P.ZZ  311 
DISCUSSION 
The experiments reported above indicate  that  the interaction  of bacterial 
endotoxin  and  rabbit  platelets  is mediated  through  some mechanism  other 
than  formation of small quantities  of thrombin.  The results reported are in 
accord  with  notion  that  endotoxin-induced  hypercoagulability  in  in  dtro 
systems is a result of platelet damage rather than its cause. 
The  immediate  release  of platelet  factors following  exposure to  thrombin 
has also been noted by Grette, who suggests that thrombin acts as a proteolytic 
substance on  some component of the platelet  surface other  than  fibrinogen 
(4). Grette has demonstrated that similar platelet injury and release of platelet 
factors can be produced by trypsin in conjunction with calcium ions. 
The  delayed  effect of  endotoxin  on  platelets  implies  an  indirect  action, 
possibly mediated through generation of proteolytic activity in plasma. Previous 
studies from this laboratory have suggested the participation  of plasma fac- 
tors in the process of platelet injury by endotoxin (1). It has been demonstrated 
that  plasma  separated from platelets  and  heated  at 56°C  centigrade  for 60 
minutes or absorbed at 37°C centigrade for 60 minutes with heterologous heat- 
killed bacterial cells is unable to produce platelet injury when remixed with 
platelets and  endotoxin.  Further,  preincubation  of plasma and  endotoxin in 
the absence of platelets resulted in greatly accelerated release  of 5 HT when 
platelets were exposed to such plasma. These observations give support to the 
concept that the action of endotoxin is indirect and involves generation of an 
injurious substance in plasma. Two facts suggest that this injurious substance 
is  not  thrombin.  First,  very large  quantities  of heparin  do  not  inhibit  the 
endotoxin-platelet interaction.  Second,  concentrations of thrombin competent 
to produce gross clot formation in citrated platelet-rich plasma are less than 
those required to cause release of platelet 5 HT. 
The belief that many types of platelet injury are due to generation of small 
quantities of thrombin is based primarily on the observation that trypsiniza- 
tion of platelets render them refractory to injury. It is assumed that the princi- 
pal effect of such treatment is the removal of fibrinogen absorbed to the platelet 
surface (2). The studies by Grette cast doubt on this formulation  (4). It has 
been demonstrated  that  platelets  incubated  with  trypsin  in  the  absence of 
calcium ions are not depleted of fibrinogen. The subsequent addition of calcium 
ions yields release,  not only of fibrinogen,  but also 5 HT and adenine nucleo- 
tides, both substances regarded as intracellular platelet factors. It is of great 
interest that this release  of intracellular platelet factors was not accompanied 
by aggregation of the platelets. Thus platelet aggregation and release of intra- 
cellular  factors  may  each  be distinct  manifestations  of platelet  injury  not 
necessarily occurring  together. 
Platelet  injury has  been observed to  occur during  the  course of antigen- 
antibody reactions both in vitro and in vivo (5-10). Platelet damage occurring 312  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  III 
during  such reactions is also resistant  to inhibition  by heparin.  Further,  this 
system requires plasma or serum factors before platelet injury occurs. In con- 
trast to the endotoxin effect, however, immunologically induced platelet injury 
requires ionized  calcium  and  is inhibited  by citrate,  not  only by removal of 
ionized calcium, but also by some mechanism independent of calcium chelation 
(2,  8,  9).  In spite  of this  dissimilarity  it  seems possible that  the  endotoxin- 
platelet interaction may also be immunologic in nature. This notion is in keep- 
ing with recent observations attributing  many of the biologic effects of endo- 
toxin to immunologic mechanisms. 
It  has  long  been  apparent  that  the  coagulation  mechanism  is  intimately 
involved in many  types of tissue injury  produced by immunologic  reactions 
or  endotoxin.  Though  the  details  of this  relationship  are  still  obscure,  it  is 
attractive  to postulate that both systems involve proteolytic injury to plate- 
let membranes. 
SUMMARY 
The  platelet  injury  produced  by bacterial  endotoxin  and  thrombin  have 
been compared in studies utilizing citrated rabbit platelet-rich  plasma.  Endo- 
toxin-induced  platelet  injury is characterized  by a  lag period,  is progressive, 
and does not produce gross clot formation.  Thrombin-induced  platelet injury 
is  immediate,  non-progressive,  and  is  associated  with  clot  formation.  The 
quantity of thrombin required to produce clot formation in this citrated system 
is less than  that required to produce release of platelet 5-hydroxytryptamine. 
The  endotoxin-induced  platelet  injury required  extremely large quantities  of 
heparin  for  inhibition.  The  platelet  injury  induced  by thrombin  can  be in- 
hibited by small quantities of heparin. It is concluded that the injurious effects 
of  endotoxin  on platelets  is  mediated  through  some mechanism  other  than 
thrombin formation. 
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